Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Dimethylfumarate induces apoptosis in human mast cells.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Full Prescribing Information, Copaxone (glatiramer acetate)
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
[The overall assessment of the quality of the physical health of patients with multiple sclerosis after the application of physical therapy. Part 1].
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Intrathecal interferon reduces exacerbations of multiple sclerosis.
Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Betaseron (Interferon Beta-1b) for SC Injection
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
The "poison chair" treatment for multiple sclerosis.
Biogen slips as FDA extends review of MS drug
Alpha/beta interferon is a neuronal growth factor.

Pages